U.S. federal trademark · Serial No. 78645559 · Reg. No. TMA695100
Product research and development in connection with the biopharmaceutical and biotechnology industries
BIOPHARMACEUTICAL AND BIOTECHNOLOGY REAGENTS, NAMELY, HYBRIDOMA-GENERATED ANTIBODIES AND MAMMALIAN ANTIBODIES AND RECOMBINANT FRAGMENTS THEREOF FOR MEDICAL DIAGNOSTIC USE IN THE TREATMENT OF CANCER; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN IMMUNOTHERAPY AND DIAGNOSTICS, NAMELY, MONOCLONAL ANTIBODIES AND BINDING FRAGMENTS THEREOF AND IMMUNOCONJUGATES, PARTICULARLY FOR TREATMENT OF CANCER; BIOTECHNOLOGY PRODUCTS FOR USE IN IMMUNOTHERAPY AND DIAGNOSTICS, NAMELY, MONOCLONAL ANTIBODIES AND BINDING FRAGMENTS THEREOF AND IMMUNOCONJUGATES, PARTICULARLY FOR THE DETECTION AND TREATMENT OF CANCER
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.